Evidence map›Paper›PMID 38239822›Full record

ArticleClinical oncology, case reports2023

Primary Undifferentiated Neoplasm of the Left Arm with Characteristics of Extragonadal Germ Cell Tumor and High-Grade Sarcoma.

Rodrigo Paredes de la Fuente, Megan E Anderson, Mary Linton B Peters

Open access · greenAbstract read
In one paragraph

Article in Clinical oncology, case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rodrigo Paredes de la FuenteDepartment of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Megan E AndersonDepartment of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston MA 02215, United States.
Mary Linton B PetersDepartment of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Beth Israel Deaconess Medical Center · US

Funding

Cost Effectiveness of Germline Genetic Testing in Pancreatic CancerK08CA248473 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PETERS, MARY LINTON B · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA248473
6 · The paper itself

Abstract

A previously healthy man in his late 20s was diagnosed with a primary undifferentiated non- metastatic tumor of the left arm. After a biopsy, a clear pathological diagnosis could not be established. The tumor had positive immunohistological markers for both an extragonadal germ cell tumor and a high-grade sarcoma. Given the presumed germ cell etiology, he was started on empiric chemotherapy with etoposide and cisplatin. After a few cycles, the tumor showed dramatic response. However, due to poor patient follow- up, it progressed to massive size with severe compromise of the joint and critical neurovascular structures, which led to the decision for limb amputation. Post-surgical checkups showed no recurrence of the primary tumor or metastasis. This is the first report in the literature showing a tumor with these histological characteristics that responded to platinum-based therapy. It provides evidence for the need of more specific markers for the pathological evaluation of undifferentiated neoplasms.

Indexed as

Case reportExtragonadal germ cell tumorHigh-grade sarcomaUndifferentiated neoplasm

Identifiers

PMID38239822
PMCPMC10795492
OpenAlexW4391036036

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.